EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Evaluation of the Oncologic Patient for Drug-Induced Pneumonitis

Terra C Swanson, Brent W Kinder, Joshua M Clark

Seminars in Respiratory and Critical Care Medicine · 01.08.2026 · 47 (04) · 446-456

DOI: 10.1055/a-2703-4574 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 01.08.2026. Verfasst von Terra C Swanson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, Unit…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Lung Diseases, Interstitial, Pneumonia. Die Arbeit nennt 106 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The National Cancer Institute (NCI) estimates that over 2 million Americans will be diagnosed with cancer in 2025. A significant proportion of these patients will receive chemotherapeutics, radiation, molecularly targeted therapies, or immunotherapies—many of which are associated with pulmonary toxicity. Drug-induced interstitial lung disease (D-ILD) is a growing and well-recognized complication of cancer-related therapies, carrying substantial morbidity and mortality. In addition to its direct health impact, D-ILD often necessitates modification or discontinuation of cancer treatment, further complicating oncologic care. As such, pulmonologists must be proficient in the evaluation and management of suspected D-ILD. In this review, we propose a structured approach to assessing patients with malignancy who present with diffuse parenchymal lung disease. We also summarize commonly implicated cancer therapies and their associated pulmonary toxicities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsLung Diseases, InterstitialPneumoniaHumans

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States.

Zitieren

APA

Swanson, T. C., Kinder, B. W., & Clark, J. M. (2026). The Evaluation of the Oncologic Patient for Drug-Induced Pneumonitis. Seminars in Respiratory and Critical Care Medicine, 47(04), 446-456. https://doi.org/10.1055/a-2703-4574

Vancouver

Swanson TC, Kinder BW, Clark JM. The Evaluation of the Oncologic Patient for Drug-Induced Pneumonitis. Seminars in Respiratory and Critical Care Medicine. 2026;47(04):446-456. doi:10.1055/a-2703-4574

BibTeX
@article{Swanson2026,
  author = {Swanson, Terra C and Kinder, Brent W and Clark, Joshua M},
  title = {The Evaluation of the Oncologic Patient for Drug-Induced Pneumonitis},
  journal = {Seminars in Respiratory and Critical Care Medicine},
  year = {2026},
  volume = {47},
  number = {04},
  pages = {446--456},
  doi = {10.1055/a-2703-4574}
}
Kostenlos starten →